<!DOCTYPE html><html lang="en" ><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><meta name="theme-color" media="(prefers-color-scheme: light)" content="#f7f7f7"><meta name="theme-color" media="(prefers-color-scheme: dark)" content="#1b1b1e"><meta name="apple-mobile-web-app-capable" content="yes"><meta name="apple-mobile-web-app-status-bar-style" content="black-translucent"><meta name="viewport" content="width=device-width, user-scalable=no initial-scale=1, shrink-to-fit=no, viewport-fit=cover" ><meta name="generator" content="Jekyll v4.3.2" /><meta property="og:title" content="Optimal Timing and Diagnostic Adequacy of Hepatocyte Phase Imaging with Gadoxetate-Enhanced Liver MRI" /><meta property="og:locale" content="en" /><meta name="description" content="Rationale and Objectives" /><meta property="og:description" content="Rationale and Objectives" /><link rel="canonical" href="https://clinicaltree.github.io/posts/optimal-timing-and-diagnostic-adequacy-of-hepatocyte-phase-imaging-with-gadoxetate-enhanced-liver-mr/" /><meta property="og:url" content="https://clinicaltree.github.io/posts/optimal-timing-and-diagnostic-adequacy-of-hepatocyte-phase-imaging-with-gadoxetate-enhanced-liver-mr/" /><meta property="og:site_name" content="Radiology Tree" /><meta property="og:type" content="article" /><meta property="article:published_time" content="2014-05-31T17:00:00+00:00" /><meta name="twitter:card" content="summary" /><meta property="twitter:title" content="Optimal Timing and Diagnostic Adequacy of Hepatocyte Phase Imaging with Gadoxetate-Enhanced Liver MRI" /><meta name="twitter:site" content="@twitter_username" /><meta name="google-site-verification" content="RFHVRgQqK0eGjftEMCTDhsDrR8cJ_ZYcfCX52gXW8KM" /> <script type="application/ld+json"> {"@context":"https://schema.org","@type":"BlogPosting","dateModified":"2023-04-10T02:43:55+00:00","datePublished":"2014-05-31T17:00:00+00:00","description":"Rationale and Objectives","headline":"Optimal Timing and Diagnostic Adequacy of Hepatocyte Phase Imaging with Gadoxetate-Enhanced Liver MRI","mainEntityOfPage":{"@type":"WebPage","@id":"https://clinicaltree.github.io/posts/optimal-timing-and-diagnostic-adequacy-of-hepatocyte-phase-imaging-with-gadoxetate-enhanced-liver-mr/"},"url":"https://clinicaltree.github.io/posts/optimal-timing-and-diagnostic-adequacy-of-hepatocyte-phase-imaging-with-gadoxetate-enhanced-liver-mr/"}</script><title>Optimal Timing and Diagnostic Adequacy of Hepatocyte Phase Imaging with Gadoxetate-Enhanced Liver MRI | Radiology Tree</title><link rel="apple-touch-icon" sizes="180x180" href="/assets/img/favicons/apple-touch-icon.png"><link rel="icon" type="image/png" sizes="32x32" href="/assets/img/favicons/favicon-32x32.png"><link rel="icon" type="image/png" sizes="16x16" href="/assets/img/favicons/favicon-16x16.png"><link rel="manifest" href="/assets/img/favicons/site.webmanifest"><link rel="shortcut icon" href="/assets/img/favicons/favicon.ico"><meta name="apple-mobile-web-app-title" content="Radiology Tree"><meta name="application-name" content="Radiology Tree"><meta name="msapplication-TileColor" content="#da532c"><meta name="msapplication-config" content="/assets/img/favicons/browserconfig.xml"><meta name="theme-color" content="#ffffff"><link rel="preconnect" href="https://fonts.googleapis.com" ><link rel="dns-prefetch" href="https://fonts.googleapis.com" ><link rel="preconnect" href="https://fonts.gstatic.com" crossorigin><link rel="dns-prefetch" href="https://fonts.gstatic.com" crossorigin><link rel="preconnect" href="https://fonts.googleapis.com" ><link rel="dns-prefetch" href="https://fonts.googleapis.com" ><link rel="preconnect" href="https://cdn.jsdelivr.net" ><link rel="dns-prefetch" href="https://cdn.jsdelivr.net" ><link rel="stylesheet" href="https://fonts.googleapis.com/css2?family=Lato&family=Source+Sans+Pro:wght@400;600;700;900&display=swap"><link rel="preconnect" href="https://www.google-analytics.com" crossorigin="use-credentials"><link rel="dns-prefetch" href="https://www.google-analytics.com"><link rel="preconnect" href="https://www.googletagmanager.com" crossorigin="anonymous"><link rel="dns-prefetch" href="https://www.googletagmanager.com"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/bootstrap@4.6.2/dist/css/bootstrap.min.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/@fortawesome/fontawesome-free@6.2.1/css/all.min.css"><link rel="stylesheet" href="/assets/css/style.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/tocbot@4.20.1/dist/tocbot.min.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/magnific-popup@1.1.0/dist/magnific-popup.min.css"> <script src="https://cdn.jsdelivr.net/npm/jquery@3.6.1/dist/jquery.min.js"></script> <script type="text/javascript"> class ModeToggle { static get MODE_KEY() { return "mode"; } static get MODE_ATTR() { return "data-mode"; } static get DARK_MODE() { return "dark"; } static get LIGHT_MODE() { return "light"; } static get ID() { return "mode-toggle"; } constructor() { if (this.hasMode) { if (this.isDarkMode) { if (!this.isSysDarkPrefer) { this.setDark(); } } else { if (this.isSysDarkPrefer) { this.setLight(); } } } let self = this; /* always follow the system prefers */ this.sysDarkPrefers.addEventListener('change', () => { if (self.hasMode) { if (self.isDarkMode) { if (!self.isSysDarkPrefer) { self.setDark(); } } else { if (self.isSysDarkPrefer) { self.setLight(); } } self.clearMode(); } self.notify(); }); } /* constructor() */ get sysDarkPrefers() { return window.matchMedia("(prefers-color-scheme: dark)"); } get isSysDarkPrefer() { return this.sysDarkPrefers.matches; } get isDarkMode() { return this.mode === ModeToggle.DARK_MODE; } get isLightMode() { return this.mode === ModeToggle.LIGHT_MODE; } get hasMode() { return this.mode != null; } get mode() { return sessionStorage.getItem(ModeToggle.MODE_KEY); } /* get the current mode on screen */ get modeStatus() { if (this.isDarkMode || (!this.hasMode && this.isSysDarkPrefer)) { return ModeToggle.DARK_MODE; } else { return ModeToggle.LIGHT_MODE; } } setDark() { $('html').attr(ModeToggle.MODE_ATTR, ModeToggle.DARK_MODE); sessionStorage.setItem(ModeToggle.MODE_KEY, ModeToggle.DARK_MODE); } setLight() { $('html').attr(ModeToggle.MODE_ATTR, ModeToggle.LIGHT_MODE); sessionStorage.setItem(ModeToggle.MODE_KEY, ModeToggle.LIGHT_MODE); } clearMode() { $('html').removeAttr(ModeToggle.MODE_ATTR); sessionStorage.removeItem(ModeToggle.MODE_KEY); } /* Notify another plugins that the theme mode has changed */ notify() { window.postMessage({ direction: ModeToggle.ID, message: this.modeStatus }, "*"); } flipMode() { if (this.hasMode) { if (this.isSysDarkPrefer) { if (this.isLightMode) { this.clearMode(); } else { this.setLight(); } } else { if (this.isDarkMode) { this.clearMode(); } else { this.setDark(); } } } else { if (this.isSysDarkPrefer) { this.setLight(); } else { this.setDark(); } } this.notify(); } /* flipMode() */ } /* ModeToggle */ const modeToggle = new ModeToggle(); </script><body data-topbar-visible="true"><div id="sidebar" class="d-flex flex-column align-items-end"><div class="profile-wrapper text-center"><div id="avatar"> <a href="/" class="mx-auto"> <img src="https://storage.googleapis.com/clinicalpub.com/images/favicon.png" alt="avatar" onerror="this.style.display='none'"> </a></div><div class="site-title"> <a href="/">Radiology Tree</a></div><div class="site-subtitle font-italic">Update every day the best and the lastest articles, books, journals, clinical cases, videos, images... for radiologist</div></div><ul class="w-100"><li class="nav-item"> <a href="/" class="nav-link"> <i class="fa-fw fas fa-home ml-xl-3 mr-xl-3 unloaded"></i> <span>HOME</span> </a><li class="nav-item"> <a href="/categories/" class="nav-link"> <i class="fa-fw fas fa-stream ml-xl-3 mr-xl-3 unloaded"></i> <span>CATEGORIES</span> </a><li class="nav-item"> <a href="/tags/" class="nav-link"> <i class="fa-fw fas fa-tag ml-xl-3 mr-xl-3 unloaded"></i> <span>TAGS</span> </a><li class="nav-item"> <a href="/archives/" class="nav-link"> <i class="fa-fw fas fa-archive ml-xl-3 mr-xl-3 unloaded"></i> <span>ARCHIVES</span> </a><li class="nav-item"> <a href="/about/" class="nav-link"> <i class="fa-fw fas fa-info-circle ml-xl-3 mr-xl-3 unloaded"></i> <span>ABOUT</span> </a></ul><div class="sidebar-bottom mt-auto d-flex flex-wrap justify-content-center align-items-center"> <button class="mode-toggle btn" aria-label="Switch Mode"> <i class="fas fa-adjust"></i> </button> <span class="icon-border"></span> <a href="https://github.com/clinicaltree" aria-label="github" target="_blank" rel="noopener noreferrer"> <i class="fab fa-github"></i> </a> <a href="https://twitter.com/twitter_username" aria-label="twitter" target="_blank" rel="noopener noreferrer"> <i class="fab fa-twitter"></i> </a> <a href="javascript:location.href = 'mailto:' + ['clinicalpub.team','gmail.com'].join('@')" aria-label="email" > <i class="fas fa-envelope"></i> </a> <a href="/feed.xml" aria-label="rss" > <i class="fas fa-rss"></i> </a></div></div><div id="topbar-wrapper"><div id="topbar" class="container d-flex align-items-center justify-content-between h-100 pl-3 pr-3 pl-md-4 pr-md-4"> <span id="breadcrumb"> <span> <a href="/"> Home </a> </span> <span>Optimal Timing and Diagnostic Adequacy of Hepatocyte Phase Imaging with Gadoxetate-Enhanced Liver MRI</span> </span> <i id="sidebar-trigger" class="fas fa-bars fa-fw"></i><div id="topbar-title"> Post</div><i id="search-trigger" class="fas fa-search fa-fw"></i> <span id="search-wrapper" class="align-items-center"> <i class="fas fa-search fa-fw"></i> <input class="form-control" id="search-input" type="search" aria-label="search" autocomplete="off" placeholder="Search..."> </span> <span id="search-cancel" >Cancel</span></div></div><div id="main-wrapper" class="d-flex justify-content-center"><div id="main" class="container pl-xl-4 pr-xl-4"><div class="row"><div id="core-wrapper" class="col-12 col-lg-11 col-xl-9 pr-xl-4"><div class="post pl-1 pr-1 pl-md-2 pr-md-2"><h1 data-toc-skip>Optimal Timing and Diagnostic Adequacy of Hepatocyte Phase Imaging with Gadoxetate-Enhanced Liver MRI</h1><div class="post-meta text-muted"> <span> Posted <em class="" data-ts="1401555600" data-df="ll" data-toggle="tooltip" data-placement="bottom"> May 31, 2014 </em> </span> <span> Updated <em class="" data-ts="1681094635" data-df="ll" data-toggle="tooltip" data-placement="bottom"> Apr 10, 2023 </em> </span><div class="d-flex justify-content-between"> <span> By <em> <a href="">Mustafa R. Bashir MD</a> </em>, <em> <a href="">Steven R. Breault MD</a> </em>, <em> <a href="">Ryan Braun MD</a> </em>, <em> <a href="">Richard K. Do MD PhD</a> </em>, <em> <a href="">Rendon C. Nelson MD</a> </em>, <em> <a href="">Scott B. Reeder MD PhD</a> </em> </span><div> <span class="readtime" data-toggle="tooltip" data-placement="bottom" title="1914 words"> <em>10 min</em> read</span></div></div></div><div class="post-content"><h2 id="rationale-and-objectives"><span class="mr-2">Rationale and Objectives</span><a href="#rationale-and-objectives" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>To evaluate clinical and imaging features associated with adequacy of the hepatocyte phase (HP) in gadoxetate disodium–enhanced liver magnetic resonance imaging (MRI) in patients without chronic liver disease (CLD).</p><h2 id="materials-and-methods"><span class="mr-2">Materials and Methods</span><a href="#materials-and-methods" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>This was a retrospective institutional review board–approved study of 97 patients who underwent liver MRI examinations with gadoxetate disodium and had no history of CLD. Available late dynamic and HP sequences (3–20 minutes postinjection) were independently analyzed by four radiologists for perceived image adequacy and level of biliary enhancement. Signal intensity ratios (SIRs) of liver/inferior vena cava (IVC), liver/spleen, and liver/muscle were measured. The Spearman ρ and receiver operating characteristic analyses were performed correlating various factors with HP adequacy. A rule for predicting HP adequacy was also derived and tested to determine whether overall examination time could be shortened.</p><h2 id="results"><span class="mr-2">Results</span><a href="#results" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>A visually adequate HP was observed in 12% of subjects by 10 minutes, 80% by 15 minutes, and 93% by 20 minutes. An SIR liver/IVC &gt; 1.8 was the imaging feature that had the strongest correlation with an adequate HP (ρ = 0.813, <em>P</em> &lt; .001), and was more predictive of adequacy of the HP than the time postinjection (ρ = 0.5, <em>P</em> &lt; .001). The time at which an adequate HP was first observed did not correlate with any tested demographic or laboratory values. Stopping imaging when an SIR liver/IVC &gt; 1.8 would have successfully reduced mean postcontrast time to 15:39 ± 4:02 from 20:00 ( <em>P</em> &lt; .001), although maintaining HP adequacy.</p><h2 id="conclusions"><span class="mr-2">Conclusions</span><a href="#conclusions" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>Most patients without CLD undergoing gadoxetate-enhanced liver MRI achieve adequate HP at 20 minutes. However, a shorter postcontrast stopping time can be used in most patients.</p><p>Gadoxetate disodium is becoming a well-established contrast agent for contrast-enhanced magnetic resonance imaging (MRI) of the noncirrhotic liver for the detection of metastatic disease and the evaluation of focal lesions . In particular, hepatocyte phase (HP) imaging with this agent along with an optimized imaging protocol has been shown to provide high-resolution imaging with strong liver-to-lesion contrast and lesion conspicuity . At many centers, gadoxetate-enhanced MRI has become the study of choice for the detection of hepatic metastases from a variety of primary tumors.</p><p>Although most publications describe the performance of the HP performed at 20 minutes postinjection, there remains debate as to whether shorter imaging times can be used for the delayed phase without compromising image quality . In particular, the use of 10-minute postinjection HP image sets has been described, with excellent performance for the detection of focal lesions . Thus the ideal timing of the HP is unclear.</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="materials-and-methods-1"><span class="mr-2">Materials and methods</span><a href="#materials-and-methods-1" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="statistical-analysis"><span class="mr-2">Statistical Analysis</span><a href="#statistical-analysis" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="results-1"><span class="mr-2">Results</span><a href="#results-1" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>Table 1</p><p>Descriptive Statistics for the Patient Cohort</p><p>Value Mean ± SD Range Number of Patients with Value Available within 4 weeks of MRI Age (years) 53.7 ± 14.0 28–85 Gender 31 M; 66 F Total bilirubin (mg/dL) 0.8 ± 0.3 0.3–1.7 N = 91 Albumin (g/dL) 3.5 ± 0.7 1.8–4.4 N = 91 Serum creatinine (mg/dL) 0.9 ± 0.3 0.5–2.3 N = 95 Estimated liver fat fraction (%) 6 ± 1 0–51 N = 97 Presence of liver lesions No lesions ( <em>n</em> = 25); hypointense lesion(s) ( <em>n</em> = 62); isointense lesion(s) ( <em>n</em> = 2); hyperintense lesion(s) ( <em>n</em> = 3); combination of lesion types ( <em>n</em> = 5)</p><p>MRI, magnetic resonance imaging; SD, standard deviation.</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/OptimalTimingandDiagnosticAdequacyofHepatocytePhaseImagingwithGadoxetateEnhancedLiverMRI/0_1s20S1076633214000841.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/OptimalTimingandDiagnosticAdequacyofHepatocytePhaseImagingwithGadoxetateEnhancedLiverMRI/0_1s20S1076633214000841.jpg" alt="Figure 1, Cumulative examination adequacy of the hepatobiliary phase over time. Of the 97 patients in this cohort, 12 (12%) reached visual adequacy by 10 minutes, 78 (80%) were adequate by 15 minutes, and 89 (92%) were adequate by 20 minutes." class="lazyload" data-proofer-ignore></a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/OptimalTimingandDiagnosticAdequacyofHepatocytePhaseImagingwithGadoxetateEnhancedLiverMRI/1_1s20S1076633214000841.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/OptimalTimingandDiagnosticAdequacyofHepatocytePhaseImagingwithGadoxetateEnhancedLiverMRI/1_1s20S1076633214000841.jpg" alt="Figure 2, ROC curves for image characteristics associated with hepatocyte phase adequacy. SIR liver/IVC was the best predictor of phase adequacy (AUROC = 0.94), followed by SIR liver/muscle (AUROC = 0.88), SIR liver/spleen (AUROC = 0.87), biliary enhancement (AUROC = 0.82), and acquisition time (AUROC = 0.80). AUROC, area under the receiver operating characteristic; IVC, inferior vena cava; SIR, signal intensity ratio. (Color version of figure is available online.)" class="lazyload" data-proofer-ignore></a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/OptimalTimingandDiagnosticAdequacyofHepatocytePhaseImagingwithGadoxetateEnhancedLiverMRI/2_1s20S1076633214000841.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/OptimalTimingandDiagnosticAdequacyofHepatocytePhaseImagingwithGadoxetateEnhancedLiverMRI/2_1s20S1076633214000841.jpg" alt="Figure 3, A 49-year-old man with hepatic adenomas. Three postcontrast images obtained at 3:58 (a) , 13:49 (b) , and 19:58 (c) after gadoxetate injection show progressive hepatic parenchymal enhancement and vessel clearance. The first image set (a) was rated an inadequate hepatocyte phase (average reader grade = 1.0, SIR LV = 1.18), whereas the second (b) and third (c) image sets were rated adequate (average reader grade = 2.0 and 2.0; SIR LV = 1.47 and 1.73, respectively). Note minimal improvement in lesion conspicuity between image set (b) , obtained at 13:49, and set (c) , obtained at 19:58 postcontrast injection. SIR, signal intensity ratio; LV liver/vein." class="lazyload" data-proofer-ignore></a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/OptimalTimingandDiagnosticAdequacyofHepatocytePhaseImagingwithGadoxetateEnhancedLiverMRI/3_1s20S1076633214000841.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/OptimalTimingandDiagnosticAdequacyofHepatocytePhaseImagingwithGadoxetateEnhancedLiverMRI/3_1s20S1076633214000841.jpg" alt="Figure 4, A 57-year-old man with renal cell carcinoma metastatic to the liver. Three postcontrast images obtained at 3:20 (a) , 12:45 (b) , and 18:47 (c) after gadoxetate injection shows progressive hepatic parenchymal enhancement and vessel clearance. The first image set (a) was rated an inadequate hepatocyte phase (average reader score = 1.0, SIR LV = 1.54), whereas the second (b) and third (c) image sets were rated adequate (average reader score = 2.0 and 2.5; SIR LV = 2.05 and 2.83, respectively). Note minimal improvement in lesion conspicuity between image set (b) , obtained at 12:45, and set (c) , obtained at 18:47 postcontrast injection. SIR, signal intensity ratio; LV liver/vein." class="lazyload" data-proofer-ignore></a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="discussion"><span class="mr-2">Discussion</span><a href="#discussion" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="conclusions-1"><span class="mr-2">Conclusions</span><a href="#conclusions-1" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="references"><span class="mr-2">References</span><a href="#references" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><ul><li><p>1. Muhi A., Ichikawa T., Motosugi U., et. al.: Diagnosis of colorectal hepatic metastases: comparison of contrast-enhanced CT, contrast-enhanced US, superparamagnetic iron oxide-enhanced MRI, and gadoxetic acid-enhanced MRI. J Magn Reson Imaging 2011; 34: pp. 326-335.</p><li><p>2. Chung W.S., Kim M.J., Chung Y.E., et. al.: Comparison of gadoxetic acid-enhanced dynamic imaging and diffusion-weighted imaging for the preoperative evaluation of colorectal liver metastases. J Magn Reson Imaging 2011; 34: pp. 345-353.</p><li><p>3. Chen L., Zhang J., Zhang L., et. al.: Meta-analysis of gadoxetic acid disodium (Gd-EOB-DTPA)-enhanced magnetic resonance imaging for the detection of liver metastases. PLoS One 2012; 7: pp. e48681.</p><li><p>4. Mohajer K., Frydrychowicz A., Robbins J.B., et. al.: Characterization of hepatic adenoma and focal nodular hyperplasia with gadoxetic acid. J Magn Reson Imaging 2012; 36: pp. 686-696.</p><li><p>5. Grazioli L., Bondioni M.P., Haradome H., et. al.: Hepatocellular adenoma and focal nodular hyperplasia: value of gadoxetic acid-enhanced MR imaging in differential diagnosis. Radiology 2012; 262: pp. 520-529.</p><li><p>6. Hyodo T., Murakami T., Imai Y., et. al.: Hypovascular nodules in patients with chronic liver disease: risk factors for development of hypervascular hepatocellular carcinoma. Radiology 2013; 266: pp. 480-490.</p><li><p>7. Bashir M.R., Gupta R.T., Davenport M.S., et. al.: Hepatocellular carcinoma in a North American population: does hepatobiliary MR imaging with Gd-EOB-DTPA improve sensitivity and confidence for diagnosis?. J Magn Reson Imaging 2013; 37: pp. 398-406.</p><li><p>8. Motosugi U., Ichikawa T., Morisaka H., et. al.: Detection of pancreatic carcinoma and liver metastases with gadoxetic acid-enhanced MR imaging: comparison with contrast-enhanced multi-detector row CT. Radiology 2011; 260: pp. 446-453.</p><li><p>9. Nagle S.K., Busse R.F., Brau A.C., et. al.: High resolution navigated three-dimensional T(1)-weighted hepatobiliary MRI using gadoxetic acid optimized for 1.5 Tesla. J Magn Reson Imaging 2012; 36: pp. 890-899.</p><li><p>10. Bashir M.R., Husarik D.B., Ziemlewicz T.J., et. al.: Liver MRI in the hepatocyte phase with gadolinium-EOB-DTPA: does increasing the flip angle improve conspicuity and detection rate of hypointense lesions?. J Magn Reson Imaging 2012; 35: pp. 611-616.</p><li><p>11. Bashir M.R., Merkle E.M.: Improved liver lesion conspicuity by increasing the flip angle during hepatocyte phase MR imaging. Eur Radiol 2011; 21: pp. 291-294.</p><li><p>12. Haradome H., Grazioli L., Al manea K., et. al.: Gadoxetic acid disodium-enhanced hepatocyte phase MRI: can increasing the flip angle improve focal liver lesion detection?. J Magn Reson Imaging 2012; 35: pp. 132-139.</p><li><p>13. Goodwin M.D., Dobson J.E., Sirlin C.B., et. al.: Diagnostic challenges and pitfalls in MR imaging with hepatocyte-specific contrast agents. Radiographics 2011; 31: pp. 1547-1568.</p><li><p>14. Sofue K., Tsurusaki M., Tokue H., et. al.: Gd-EOB-DTPA-enhanced 3.0 T MR imaging: quantitative and qualitative comparison of hepatocyte-phase images obtained 10 min and 20 min after injection for the detection of liver metastases from colorectal carcinoma. Eur Radiol 2011; 21: pp. 2336-2343.</p><li><p>15. Ringe K.I., Husarik D.B., Sirlin C.B., et. al.: Gadoxetate disodium-enhanced MRI of the liver: part 1, protocol optimization and lesion appearance in the noncirrhotic liver. AJR Am J Roentgenol 2010; 195: pp. 13-28.</p><li><p>16. Jeong H.T., Kim M.J., Park M.S., et. al.: Detection of liver metastases using gadoxetic-enhanced dynamic and 10- and 20-minute delayed phase MR imaging. J Magn Reson Imaging 2012; 35: pp. 635-643.</p><li><p>17. Dixon W.T.: Simple proton spectroscopic imaging. Radiology 1984; 153: pp. 189-194.</p><li><p>18. Ma J.: Breath-hold water and fat imaging using a dual-echo two-point Dixon technique with an efficient and robust phase-correction algorithm. Magn Reson Med 2004; 52: pp. 415-419.</p><li><p>19. Feuerlein S., Boll D.T., Gupta R.T., et. al.: Gadoxetate disodium-enhanced hepatic MRI: dose-dependent contrast dynamics of hepatic parenchyma and portal vein. AJR Am J Roentgenol 2011; 196: pp. W18-W24.</p><li><p>20. Reeder S.B., Robson P.M., Yu H., et. al.: Quantification of hepatic steatosis with MRI: the effects of accurate fat spectral modeling. J Magn Reson Imaging 2009; 29: pp. 1332-1339.</p><li><p>21. Cruite I., Schroeder M., Merkle E.M., et. al.: Gadoxetate disodium-enhanced MRI of the liver: part 2, protocol optimization and lesion appearance in the cirrhotic liver. AJR Am J Roentgenol 2010; 195: pp. 29-41.</p><li><p>22. Frydrychowicz A., Lubner M.G., Brown J.J., et. al.: Hepatobiliary MR imaging with gadolinium-based contrast agents. J Magn Reson Imaging 2012; 35: pp. 492-511.</p><li><p>23. Muhi A., Ichikawa T., Motosugi U., et. al.: Diffusion- and T(2)-weighted MR imaging of the liver: effect of intravenous administration of gadoxetic acid disodium. Magn Reson Med Sci 2012; 11: pp. 185-191.</p><li><p>24. Ahn S.J., Kim M.J., Hong H.S., et. al.: Distinguishing hemangiomas from malignant solid hepatic lesions: a comparison of heavily T2-weighted images obtained before and after administration of gadoxetic acid. J Magn Reson Imaging 2011; 34: pp. 310-317.</p><li><p>25. Kim Y.K., Kwak H.S., Kim C.S., et. al.: Detection and characterization of focal hepatic tumors: a comparison of T2-weighted MR images before and after the administration of gadoxectic acid. J Magn Reson Imaging 2009; 30: pp. 437-443.</p><li><p>26. Motosugi U., Ichikawa T., Tominaga L., et. al.: Delay before the hepatocyte phase of Gd-EOB-DTPA-enhanced MR imaging: is it possible to shorten the examination time?. Eur Radiol 2009; 19: pp. 2623-2629.</p><li><p>27. Corwin M.T., Karam A.R., Baker S.P., et. al.: Determination of cystic duct patency using hepatobiliary MRI with gadoxetate disodium: is T1 precontrast imaging necessary?. J Magn Reson Imaging 2012; 35: pp. 601-606.</p><li><p>28. Lee N.K., Kim S., Lee J.W., et. al.: Biliary MR imaging with Gd-EOB-DTPA and its clinical applications. Radiographics 2009; 29: pp. 1707-1724.</p><li><p>29. Ringe K.I., Husarik D.B., Gupta R.T., et. al.: Hepatobiliary transit times of gadoxetate disodium (Primovist(R)) for protocol optimization of comprehensive MR imaging of the biliary system—what is normal?. Eur J Radiol 2011; 79: pp. 201-205.</p><li><p>30. Tschirch F.T., Struwe A., Petrowsky H., et. al.: Contrast-enhanced MR cholangiography with Gd-EOB-DTPA in patients with liver cirrhosis: visualization of the biliary ducts in comparison with patients with normal liver parenchyma. Eur Radiol 2008; 18: pp. 1577-1586.</p><li><p>31. Frydrychowicz A., Jedynak A.R., Kelcz F., et. al.: Gadoxetic acid-enhanced T1-weighted MR cholangiography in primary sclerosing cholangitis. J Magn Reson Imaging 2012; 36: pp. 632-640.</p><li><p>32. Davenport M.S., Viglianti B.L., Al-Hawary M.M., et. al.: Comparison of acute transient dyspnea after intravenous administration of gadoxetate disodium and gadobenate dimeglumine: effect on arterial phase image quality. Radiology 2013; 266: pp. 452-461.</p><li><p>33. Kim M.J., Rhee H.J., Jeong H.T.: Hyperintense lesions on gadoxetate disodium-enhanced hepatobiliary phase imaging. AJR Am J Roentgenol 2012; 199: pp. W575-W586.</p><li><p>34. Nassif A., Jia J., Keiser M., et. al.: Visualization of hepatic uptake transporter function in healthy subjects by using gadoxetic acid-enhanced MR imaging. Radiology 2012; 264: pp. 741-750.</p><li><p>35. Noren B., Forsgren M.F., Dahlqvist Leinhard O., et. al.: Separation of advanced from mild hepatic fibrosis by quantification of the hepatobiliary uptake of Gd-EOB-DTPA. Eur Radiol 2013; 23: pp. 174-181.</p><li><p>36. Sourbron S., Sommer W.H., Reiser M.F., et. al.: Combined quantification of liver perfusion and function with dynamic gadoxetic acid-enhanced MR imaging. Radiology 2012; 263: pp. 874-883.</p></ul></div><div class="post-tail-wrapper text-muted"><div class="post-meta mb-3"> <i class="far fa-folder-open fa-fw mr-1"></i> <a href='/categories/academic-radiology/'>Academic Radiology</a>, <a href='/categories/volume-21/'>Volume 21</a>, <a href='/categories/issue-6/'>Issue 6</a></div><div class="post-tags"> <i class="fa fa-tags fa-fw mr-1"></i> <a href="/tags/journals/" class="post-tag no-text-decoration" >Journals</a> <a href="/tags/general-radiology/" class="post-tag no-text-decoration" >General Radiology</a></div><div class="post-tail-bottom d-flex justify-content-between align-items-center mt-3 pt-5 pb-2"><div class="license-wrapper"> This post is licensed under <a href="https://creativecommons.org/licenses/by/4.0/"> CC BY 4.0 </a> by the author.</div><div class="share-wrapper"> <span class="share-label text-muted mr-1">Share</span> <span class="share-icons"> <a href="https://twitter.com/intent/tweet?text=Optimal%20Timing%20and%20Diagnostic%20Adequacy%20of%20Hepatocyte%20Phase%20Imaging%20with%20Gadoxetate-Enhanced%20Liver%20MRI%20-%20Radiology%20Tree&url=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Foptimal-timing-and-diagnostic-adequacy-of-hepatocyte-phase-imaging-with-gadoxetate-enhanced-liver-mr%2F" data-toggle="tooltip" data-placement="top" title="Twitter" target="_blank" rel="noopener" aria-label="Twitter"> <i class="fa-fw fab fa-twitter"></i> </a> <a href="https://www.facebook.com/sharer/sharer.php?title=Optimal%20Timing%20and%20Diagnostic%20Adequacy%20of%20Hepatocyte%20Phase%20Imaging%20with%20Gadoxetate-Enhanced%20Liver%20MRI%20-%20Radiology%20Tree&u=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Foptimal-timing-and-diagnostic-adequacy-of-hepatocyte-phase-imaging-with-gadoxetate-enhanced-liver-mr%2F" data-toggle="tooltip" data-placement="top" title="Facebook" target="_blank" rel="noopener" aria-label="Facebook"> <i class="fa-fw fab fa-facebook-square"></i> </a> <a href="https://t.me/share/url?url=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Foptimal-timing-and-diagnostic-adequacy-of-hepatocyte-phase-imaging-with-gadoxetate-enhanced-liver-mr%2F&text=Optimal%20Timing%20and%20Diagnostic%20Adequacy%20of%20Hepatocyte%20Phase%20Imaging%20with%20Gadoxetate-Enhanced%20Liver%20MRI%20-%20Radiology%20Tree" data-toggle="tooltip" data-placement="top" title="Telegram" target="_blank" rel="noopener" aria-label="Telegram"> <i class="fa-fw fab fa-telegram"></i> </a> <i id="copy-link" class="fa-fw fas fa-link small" data-toggle="tooltip" data-placement="top" title="Copy link" data-title-succeed="Link copied successfully!"> </i> </span></div></div></div></div></div><div id="panel-wrapper" class="col-xl-3 pl-2 text-muted"><div class="access"><div id="access-lastmod" class="post"><div class="panel-heading">Recently Updated</div><ul class="post-content pl-0 pb-1 ml-1 mt-2"><li><a href="/posts/neurometabolites-alteration-in-the-acute-phase-of-mild-traumatic-brain-injury-mtbi/">Neurometabolites Alteration in the Acute Phase of Mild Traumatic Brain Injury (mTBI)</a><li><a href="/posts/reinforcing-the-importance-and-feasibility-of-implementing-a-low-dose-protocol-for-ct-guided-biopsie/">Reinforcing the Importance and Feasibility of Implementing a Low-dose Protocol for CT-guided Biopsies</a><li><a href="/posts/rethinking-the-pgy-1-basic-clinical-year/">Rethinking the PGY-1 Basic Clinical Year</a><li><a href="/posts/single-injection-dual-phase-cone-beam-ct-dp-cbct-vascular-anatomy-assessment-and-occult-nodule-det/">Single Injection Dual-Phase Cone Beam CT (DP-CBCT) Vascular Anatomy Assessment and Occult Nodule Detection; Have We Reached the Focus?</a><li><a href="/posts/the-yellow-scale-is-superior-to-the-gray-scale-for-detecting-acute-ischemic-stroke-on-a-monitor-disp/">The Yellow Scale Is Superior to the Gray Scale for Detecting Acute Ischemic Stroke on a Monitor Display in Computed Tomography</a></ul></div><div id="access-tags"><div class="panel-heading">Trending Tags</div><div class="d-flex flex-wrap mt-3 mb-1 mr-3"> <a class="post-tag" href="/tags/general-radiology/">General Radiology</a> <a class="post-tag" href="/tags/journals/">Journals</a></div></div></div><div id="toc-wrapper" class="pl-0 pr-4 mb-5"><div class="panel-heading pl-3 pt-2 mb-2">Contents</div><nav id="toc"></nav></div><script src="https://cdn.jsdelivr.net/npm/tocbot@4.20.1/dist/tocbot.min.js"></script></div></div><div class="row"><div id="tail-wrapper" class="col-12 col-lg-11 col-xl-9 pl-3 pr-3 pr-xl-4 mt-5"><div id="related-posts" class="mb-2 mb-sm-4"><h3 class="pt-2 mb-4 ml-1" data-toc-skip>Further Reading</h3><div class="card-deck mb-4"><div class="card"> <a href="/posts/assessment-of-tumor-grade-and-angiogenesis-in-colorectal-cancer/"><div class="card-body"> <em class="small" data-ts="1401555600" data-df="ll" > May 31, 2014 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>Assessment of Tumor Grade and Angiogenesis in Colorectal Cancer</h3><div class="text-muted small"><p> Rationale and Objectives The preoperative evaluation of tumor grading and angiogenesis has important clinical implications in the treatment and prognosis of patients with colorectal cancers (CRCs)...</p></div></div></a></div><div class="card"> <a href="/posts/contrast-enhanced-magnetic-resonance-angiog-raphy-for-the-preoperative-evaluation-of-hepatic-vascula/"><div class="card-body"> <em class="small" data-ts="1401555600" data-df="ll" > May 31, 2014 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>Contrast-enhanced Magnetic Resonance Angiog raphy for the Preoperative Evaluation of Hepatic Vascular Anatomy in Living Liver Donors</h3><div class="text-muted small"><p> Rationale and Objectives The objective of this study was to determine the diagnostic accuracy of contrast-enhanced magnetic resonance angiography (MRA) when used in the preoperative evaluation of ...</p></div></div></a></div><div class="card"> <a href="/posts/evaluation-of-coronary-artery-image-quality-with-knowledge-based-iterative-model-reconstruction/"><div class="card-body"> <em class="small" data-ts="1401555600" data-df="ll" > May 31, 2014 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>Evaluation of Coronary Artery Image Quality with Knowledge-based Iterative Model Reconstruction</h3><div class="text-muted small"><p> Rationale and Objectives To evaluate knowledge-based iterative model reconstruction (IMR) to improve image quality and reduce radiation dose in coronary computed tomography angiography (cCTA). Ma...</p></div></div></a></div></div></div><div class="post-navigation d-flex justify-content-between"> <a href="/posts/model-based-iterative-reconstruction-compared-to-adaptive-statistical-iterative-reconstruction-and-f/" class="btn btn-outline-primary" prompt="Older"><p>Model-based Iterative Reconstruction Compared to Adaptive Statistical Iterative Reconstruction and Filtered Back-projection in CT of the Kidneys and the Adjacent Retroperitoneum</p></a> <a href="/posts/optimizing-image-contrast-display-improves-quantitative-stenosis-measurement-in-heavily-calcified-co/" class="btn btn-outline-primary" prompt="Newer"><p>Optimizing Image Contrast Display Improves Quantitative Stenosis Measurement in Heavily Calcified Coronary Arterial Segments on Coronary CT Angiography</p></a></div></div></div></div><div id="search-result-wrapper" class="d-flex justify-content-center unloaded"><div class="col-12 col-sm-11 post-content"><div id="search-hints"><div id="access-tags"><div class="panel-heading">Trending Tags</div><div class="d-flex flex-wrap mt-3 mb-1 mr-3"> <a class="post-tag" href="/tags/general-radiology/">General Radiology</a> <a class="post-tag" href="/tags/journals/">Journals</a></div></div></div><div id="search-results" class="d-flex flex-wrap justify-content-center text-muted mt-3"></div></div></div></div><footer><div class="container pl-lg-4 pr-lg-4"><div class="d-flex justify-content-between align-items-center text-muted ml-md-3 mr-md-3"><div class="footer-left"><p class="mb-0"> © 2023 <a href="https://twitter.com/username">Clinical Team</a>. <span data-toggle="tooltip" data-placement="top" title="Except where otherwise noted, the blog posts on this site are licensed under the Creative Commons Attribution 4.0 International (CC BY 4.0) License by the author.">Some rights reserved.</span></p></div><div class="footer-right"><p class="mb-0">Using the <a href="https://jekyllrb.com" target="_blank" rel="noopener">Jekyll</a> theme <a href="https://github.com/cotes2020/jekyll-theme-chirpy" target="_blank" rel="noopener">Chirpy</a>.</p></div></div></div></footer><div id="mask"></div><a id="back-to-top" href="#" aria-label="back-to-top" class="btn btn-lg btn-box-shadow" role="button"> <i class="fas fa-angle-up"></i> </a><div id="notification" class="toast" role="alert" aria-live="assertive" aria-atomic="true" data-animation="true" data-autohide="false"><div class="toast-header"> <button type="button" class="ml-2 ml-auto close" data-dismiss="toast" aria-label="Close"> <span aria-hidden="true">&times;</span> </button></div><div class="toast-body text-center pt-0"><p class="pl-2 pr-2 mb-3">A new version of content is available.</p><button type="button" class="btn btn-primary" aria-label="Update"> Update </button></div></div><script src="https://cdn.jsdelivr.net/npm/simple-jekyll-search@1.10.0/dest/simple-jekyll-search.min.js"></script> <script> SimpleJekyllSearch({ searchInput: document.getElementById('search-input'), resultsContainer: document.getElementById('search-results'), json: '/assets/js/data/search.json', searchResultTemplate: '<div class="pl-1 pr-1 pl-sm-2 pr-sm-2 pl-lg-4 pr-lg-4 pl-xl-0 pr-xl-0"> <a href="{url}">{title}</a><div class="post-meta d-flex flex-column flex-sm-row text-muted mt-1 mb-1"> {categories} {tags}</div><p>{snippet}</p></div>', noResultsText: '<p class="mt-5">Oops! No results found.</p>', templateMiddleware: function(prop, value, template) { if (prop === 'categories') { if (value === '') { return `${value}`; } else { return `<div class="mr-sm-4"><i class="far fa-folder fa-fw"></i>${value}</div>`; } } if (prop === 'tags') { if (value === '') { return `${value}`; } else { return `<div><i class="fa fa-tag fa-fw"></i>${value}</div>`; } } } }); </script> <script src="https://cdn.jsdelivr.net/combine/npm/magnific-popup@1.1.0/dist/jquery.magnific-popup.min.js,npm/lazysizes@5.3.2/lazysizes.min.js,npm/clipboard@2.0.11/dist/clipboard.min.js"></script> <script src="https://cdn.jsdelivr.net/combine/npm/dayjs@1.11.6/dayjs.min.js,npm/dayjs@1.11.6/locale/en.min.js,npm/dayjs@1.11.6/plugin/relativeTime.min.js,npm/dayjs@1.11.6/plugin/localizedFormat.min.js"></script> <script defer src="/assets/js/dist/post.min.js"></script> <script src="https://cdn.jsdelivr.net/npm/bootstrap@4.6.2/dist/js/bootstrap.bundle.min.js"></script> <script defer src="/app.js"></script> <script defer src="https://www.googletagmanager.com/gtag/js?id=G-L66SLQK23K"></script> <script> document.addEventListener("DOMContentLoaded", function(event) { window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-L66SLQK23K'); }); </script>
